
MOSCOW (Reuters) -A Russian Soyuz MS-28 spacecraft with two Russian cosmonauts and one NASA astronaut on board successfully docked with the International Space Station on Thursday, Russian space agency Roscosmos said.
But the agency later reported that the launch pad at the Baikonur Cosmodrome in Kazakhstan had sustained damage from the launch. It said the damage would be quickly repaired.
The Soyuz 2.1a rocket lifted off from the Baikonur Cosmodrome at 12:28 p.m. Moscow time (0928 GMT).
Late on Thursday, Russian news agencies quoted Roscosmos as saying the launch had taken place without incident, but damage was observed after an inspection of the launch area.
"Damage to a number of elements of the launch pad was detected. An assessment of the state of the launch complex is being conducted now," the agencies quoted Roscosmos as saying.
"All the necessary reserve elements are there to restore it and the damage will be eliminated very soon."
It said the crew was on board the station and in good health.
(Reporting by Anastasia Lyrchikova; Writing by Marina Bobrova; Editing by Andrew Osborn, Ron Popeski and Bill Berkrot)
latest_posts
- 1
Instructions to Safeguard Your Speculations In the midst of Changing Disc Rates - 2
Why doing good also makes us feel good, during the holidays and beyond - 3
Hamas Navy head, engineer of Khan Yunis tunnel network killed in Gaza, IDF confirms - 4
Must-Have Wellness Gear: What to Purchase for Successful Exercises - 5
Find the Standards of Viable Refereeing: Settling Debates with Strategy
Share your pick for the miniature headphones that you generally suggest!
Figure out how to Amplify Your Open Record Reward
Get To Be familiar with The Historical backdrop Of Western Medication
The Advancement and Effect of Dental Embed Innovation on Oral Wellbeing
Family-Accommodating Snow Sports Experiences
Excelling at Cash The board: A Manual for Monetary Essentials
The Magnificence of Do-It-Yourself Skincare: Regular Recipes and Tips
Eating ultra-processed foods could raise precancerous polyp risk for women under 50, according to research
CDC advisory panel delays vote on hepatitis B vaccines after unruly meeting













